Shum Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.29M Sell
5,145
-99
-2% -$21.3K 0.78% 34
2026
Q1
$1.14M Buy
5,244
+17
+0.3% +$3.77K 0.81% 33
2025
Q4
$1.19M Sell
5,227
-109
-2% -$24.8K 0.86% 32
2025
Q3
$1.24M Buy
+5,336
New +$1.09M 0.92% 30
2025
Q1
$1.18M Buy
5,631
+77
+1% +$15K 1.02% 33
2024
Q4
$987K Buy
5,554
+44
+0.8% +$8.09K 0.85% 39
2024
Q3
$1.11M Buy
+5,510
New +$1.03M 0.93% 35

Other funds holding ABBV

Shum Financial Group's ABBV Position: Q2 2026 in Review

Shum Financial Group reduced its AbbVie (ABBV) stake by 1.9% in Q2 2026, selling an estimated $21.3K and leaving 5,145 shares worth $1.29M. The position accounts for 0.78% of the portfolio, ranked #34.

Shum Financial Group first reported a position in ABBV in Q3 2024 and has held it in 7 quarters since. 2,661 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Shum Financial Group held 5,145 shares of AbbVie worth $1.29M as of Q2 2026.
  • Shum Financial Group sold 99 AbbVie shares in Q2 2026, an estimated $21.3K.
  • AbbVie made up 0.78% of Shum Financial Group's portfolio in Q2 2026, its #34 holding.
  • Shum Financial Group first reported a position in AbbVie in Q3 2024 and has held it in 7 quarters since.
  • 2,661 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Shum Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.